159 completed. 159 Phase 3, 25 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 159 | Completed 159 |
| Phase 2 | 25 | Completed 25 |
Follow Malaria: new trials by email Literature Review of Malaria trials Research Report on Malaria
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Parasite Clearance and Protection From Infection (PCPI) in Zambia SP (Macleods Pharmaceuticals Ltd), AS (Guilin Pharmaceuticals) - Malaria | Phase 3 | Completed | London School of Hygiene and Tropical Medicine | 600 | 2024-07-24 | 2025-03-12 |
| Parasite Clearance and Protection From Infection (PCPI) in Cameroon SP (Macleods Pharmaceuticals Ltd), SPAQ (Guilin Pharmaceuticals), AS (Guilin Pharmaceuticals) - Malaria | Phase 3 | Completed | London School of Hygiene and Tropical Medicine | 902 | 2024-06-10 | 2025-03-12 |
| Efficacy, Safety and Tolerability of KLU156 in Adults and Children With Uncomplicated P. Falciparum Malaria KLU156, Coartem - Uncomplicated Plasmodium Falciparum Malaria | Phase 3 | Completed | Novartis Pharmaceuticals | 1720 | 2024-03-07 | 2026-11-04 |
| Field Evaluations of Innovative Tools for Vector-borne Disease Control in Conflict-affected Communities Mesh - spatial repellent impregnated with transfluthrin (2500mg), Information and Education Campaigns (IEC), test and treat malaria cases - Malaria, Childhood ALL | Phase 3 | Completed | The Mentor Initiative | 2400 | 2023-06-05 | 2024-04-23 |
| Triple Artemisinin-based Combination Therapy for Delaying Drug Resistance Development - a Randomized Clinical Trial Artemether-lumefantrine and Amodiaquine Drug Combination, Artemether-lumefantrine then Artesunate amodiaquine, Artemether-lumefantrine - Uncomplicated Plasmodium Falciparum Malaria | Phase 2 / Phase 3 | Completed | Muhimbili University of Health and Allied Sciences | 384 | 2023-05-01 | 2026-09-23 |
| Broad One Health Endectocide-based Malaria Intervention in Africa (BOHEMIA) Albendazole Pill, Ivermectin Pill, Ivermectin Injectable Product - Malaria | Phase 3 | Completed | Barcelona Institute for Global Health | 48145 | 2022-03-17 | 2025-03-14 |
| A Trial to Compare the Efficacy, Safety and Tolerability of Combinations of 3 Anti-malarial Drugs Against Combinations of 2 Anti-malarial Drugs (Asia) Artemether-lumefantrine+amodiaquine, Artemether-lumefantrine+placebo, Artesunate-mefloquine+piperaquine - Plasmodium Falciparum Malaria (Uncomplicated) | Phase 3 | Completed | University of Oxford | 103 | 2021-06-30 | 2024-03-20 |
| Comparison of ISTp- PYRAMAX-US-RDT to IPTp-SP to Prevent Malaria in Pregnant Women in DRC (ULTRAPYRAPREG) Sulfadoxine pyrimethamine, Pyramax - Malaria in Pregnancy | Phase 3 | Completed | University of Kinshasa | 250 | 2021-05-06 | 2022-11-04 |
| Effectiveness of Novel Approaches to Radical Cure With Tafenoquine and Primaquine Tafenoquine, Primaquine - Vivax Malaria, Plasmodium Vivax | Phase 3 | Completed | Menzies School of Health Research | 960 | 2021-04-25 | 2024-10-08 |
| Dihydroartemisinin-Piperaquine or Sulphadoxine-Pyrimethamine for the Chemoprevention of Malaria in Sickle Cell Anaemia Dihydroartemisinin Piperaquine - Sickle Cell Anemia in Children, Malaria | Phase 3 | Completed | Liverpool School of Tropical Medicine | 723 | 2021-04-09 | 2023-09-13 |
| Improving Care Through Azithromycin Research for Infants in Africa Azithromycin, Placebo - Child Mortality | Phase 3 | Completed | Barcelona Institute for Global Health | 20560 | 2021-03-15 | 2026-11-06 |
| Malaria as a Risk Factor for COVID-19 in Western Kenya and Burkina Faso Artemether-lumefantrine (AL), Pyronaridine-artesunate (PA) - Covid-19, Malaria | Phase 3 | Completed | Liverpool School of Tropical Medicine | 143 | 2021-01-08 | 2024-02-23 |
| Optimal Chemopreventive Regimens to Prevent Malaria and Improve Birth Outcomes in Uganda Sulfadoxine-pyrimethamine (SP), Dihydroartemisinin-piperaquine (DP) - Malaria | Phase 3 | Completed | Grant Dorsey, M.D, Ph.D. | 2757 | 2020-12-28 | 2025-11-06 |
| A Trial to Compare the Efficacy, Safety and Tolerability of Combinations of 3 Anti-malarial Drugs Against Combina-tions of 2 Anti-malarial Drugs. Artemether-lumefantrine+ Amodiaquine (AL+AQ), Artemether-lumefantrine + placebo (AL+PBO), Artesunate-mefloquine+piperaquine (AS-MQ+PPQ) - Plasmodium Falciparum Malaria (Uncomplicated) | Phase 3 | Completed | University of Oxford | 2583 | 2020-09-01 | 2025-11-18 |
| Additional Screening With Sensitives RDTs and Malaria Additional screening using ultra sensitive RDTs, Dihydroartemisinin-piperaquin, Reminders - Plasmodium Falciparum Malaria, Malaria Diagnosis | Phase 3 | Completed | Institut de Recherche en Sciences de la Sante, Burkina Faso | 340 | 2020-08-31 | 2023-03-30 |
| Seasonal Malaria Vaccination (RTS,S/AS01) and Seasonal Malaria Chemoprevention (SP/AQ) Extension Study Tetanus/diphtheria toxoids, SMC with SP+AQ, RTS,S/AS01 - Malaria,Falciparum, Child, Only | Phase 3 | Completed | London School of Hygiene and Tropical Medicine | 5098 | 2020-04-01 | 2024-09-20 |
| Improving PRegnancy Outcomes With PReVEntive Therapy in Africa-2 (IMPROVE-2) Intermittent Preventive Therapy with Dihydroartemisinin-Piperaquine - Pregnancy; HIV; Malaria | Phase 3 | Completed | Liverpool School of Tropical Medicine | 898 | 2019-11-11 | 2023-08-22 |
| Improving Maternal heAlth by Reducing Malaria in African HIV Women Dihydroartemisinin-piperaquine (DHA-PPQ), Placebo Oral Tablet - Malaria, HIV/AIDS | Phase 3 | Completed | Barcelona Institute for Global Health | 666 | 2019-09-18 | 2024-10-01 |
| Pyronaridine-artesunate With Low Dose Primaquine for Preventing P. Falciparum Transmission Pyronaridine Tetraphosphate/Artesunate, Dihydroartemisinin/Piperaquine, Primaquine Diphosphate - Malaria,Falciparum | Phase 2 / Phase 3 | Completed | London School of Hygiene and Tropical Medicine | 100 | 2019-09-12 | 2020-01-30 |
| Repeat Ivermectin Mass Drug Administrations for MALaria Control II Ivermectin, Placebo oral tablet - Malaria | Phase 3 | Completed | Brian Foy | 4124 | 2019-07-13 | 2025-04-10 |
Showing 20 of 159. Sign in to see all of them.
Malaria, Falciparum (47) · Malaria, Vivax (14) · Anemia (7) · HIV Infections (5) · Anemia, Sickle Cell (3) · Acquired Immunodeficiency Syndrome (2) · Glucosephosphate Dehydrogenase Deficiency (2) · Hemolysis (2) · Infections (2) · Malaria, Cerebral (2) · Protozoan Infections (2) · Recurrence (2) · Anemia, Hemolytic (1) · Asymptomatic Infections (1)
Mosquito-Borne Diseases (159) · Parasitic Diseases (158) · Vector Borne Diseases (158) · Infections (157) · Protozoan Infections (157) · Hemic and Lymphatic Diseases (14) · Hematologic Diseases (13) · Pathological Conditions, Signs and Symptoms (10) · Communicable Diseases (9) · Genital Diseases (9) · Urogenital Diseases (9) · Virus Diseases (9) · Blood-Borne Infections (8) · Immune System Diseases (8)
Artemether, Lumefantrine Drug Combination (33) · fanasil, pyrimethamine drug combination (31) · Chloroquine (22) · Artesunate (17) · Amodiaquine (16) · Primaquine (16) · amodiaquine, artesunate drug combination (11) · Azithromycin (10) · pyronaridine tetraphosphate, artesunate drug combination (9) · piperaquine (7) · Mefloquine (6) · chloroguanil, dapsone drug combination (6) · Ivermectin (5) · Pyrimethamine (4) · Vitamin A (4)
London School of Hygiene and Tropical Medicine (43) · University of Oxford (12) · GlaxoSmithKline (10) · University of California, San Francisco (9) · Institute of Tropical Medicine, Belgium (6) · Liverpool School of Tropical Medicine (5) · Medicines for Malaria Venture (5) · Pfizer (5) · Menzies School of Health Research (4) · Barcelona Institute for Global Health (3) · Institut de Recherche pour le Developpement (3) · Centers for Disease Control and Prevention (2) · Grant Dorsey, M.D, Ph.D. (2) · Indiana University (2) · Makerere University (2)
Burkina Faso (28) · Uganda (24) · Kenya (23) · Ghana (17) · Tanzania (16) · Mali (14) · The Gambia (12) · Mozambique (9) · Nigeria (9) · Democratic Republic of the Congo (8) · Gabon (7) · Malawi (7) · Senegal (7) · Thailand (7) · Cambodia (6)
Grant Dorsey, MD, PhD (6) · Diane V Havlir, MD (4) · Brian Greenwood, FRCP, FRS (3) · Brian Greenwood, MD (3) · Jayaram Menon, MBBS (3) · Paul J Milligan, PhD (3) · Tsin Yeo, MBBS (3) · Alassane Dicko, Professor (2) · Arjen Dondorp, MD (2) · Badara Cisse, PhD (2) · Brian D. Foy, PhD (2) · Bridget Barber, MBBS (2) · Clara Menendez, MD, PhD (2)
PMID 23433102, PMID 26666916, PMID 39324693, PMID 21849081, PMID 22993389, PMID 25425434, PMID 29547881, PMID 33020153, PMID 35732155, PMID 36534705, PMID 12510893, PMID 16503464, PMID 16551365, PMID 16640611, PMID 17046467, PMID 17239256, PMID 17519409, PMID 17519410, PMID 17940319, PMID 17971864, PMID 18074034, PMID 18171245, PMID 18213379, PMID 18237394, PMID 18522503, PMID 18547415, PMID 18547416, PMID 18582194, PMID 18598190, PMID 18620950, PMID 18682739, PMID 18752443, PMID 18926569, PMID 19038036, PMID 19098989, PMID 19199542, PMID 19352498, PMID 19366448, PMID 19505304, PMID 19656069, PMID 19690618, PMID 19765815, PMID 19765816, PMID 19769536, PMID 19784374, PMID 19789648, PMID 19843332, PMID 19877969, PMID 19948038, PMID 20209126
P01HD059454 (2), R01AI104702 (1), U01AI126610 (1), U01AI138910 (1)